Concepedia

Author

Thomas Vanhove

KU LeuvenORCID

Also Known As

T Vanhove, T. Vanhove, Thomas Vanhove, VANHOVE T

30

Publications

906

Citations

14

H-Index

7

Concepts

All Affiliations

KU LeuvenUniversity Medical Center UtrechtKarolinska University HospitalKarolinska Institutet
TV

About

Thomas Vanhove is an author at KU Leuven specializing in molecular pharmacology, urology, and renal inflammation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

21

2

Nephrology

1

1

21

3

Pharmacology

1

1

21

4

Molecular Pharmacology

1

1

21

5

Renal Inflammation

1

1

21

Thomas Vanhove

×

14

Publications

572

Citations

13

H-Index

YearCitations

High Intrapatient Variability of Tacrolimus Concentrations Predicts Accelerated Progression of Chronic Histologic Lesions in Renal Recipients

Thomas Vanhove, Tom Vermeulen, Pieter Annaert,

American Journal of Transplantation

2016

130

Determinants of the Magnitude of Interaction Between Tacrolimus and Voriconazole/Posaconazole in Solid Organ Recipients

Thomas Vanhove, Hanneke Bouwsma, Luuk B. Hilbrands,

American Journal of Transplantation

2017

86

Reasons for dose reduction of mycophenolate mofetil during the first year after renal transplantation and its impact on graft outcome

Thomas Vanhove, Dirk Kuypers, Kathleen Claes,

Transplant International

2013

64

Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocrit

Hylke de Jonge, Thomas Vanhove, Henriëtte de Loor,

British Journal of Clinical Pharmacology

2015

56

Effect of the Direct Oral Anticoagulants Rivaroxaban and Apixaban on the Disposition of Calcineurin Inhibitors in Transplant Recipients

Thomas Vanhove, Isabel Spriet, Pieter Annaert,

Therapeutic Drug Monitoring

2016

43

Histological characteristics of Acute Tubular Injury during Delayed Graft Function predict renal function after renal transplantation

Tobias T. Pieters, Lucas L. Falke, Tri Q. Nguyen,

Physiological Reports

2019

43

Comparative performance of oral midazolam clearance and plasma 4β‐hydroxycholesterol to explain interindividual variability in tacrolimus clearance

Thomas Vanhove, Hylke de Jonge, Henriëtte de Loor,

British Journal of Clinical Pharmacology

2016

29

A noninferiority trial comparing a heparin-grafted membrane plus citrate-containing dialysate versus regional citrate anticoagulation: results of the CiTED study

Björn Meijers, Christoph Metalidis, Thomas Vanhove,

Nephrology Dialysis Transplantation

2017

29

Effect of ABCB1 diplotype on tacrolimus disposition in renal recipients depends on CYP3A5 and CYP3A4 genotype

Thomas Vanhove, Pieter Annaert, Diether Lambrechts,

The Pharmacogenomics Journal

2016

21

Relationship between In Vivo CYP3A4 Activity, CYP3A5 Genotype, and Systemic Tacrolimus Metabolite/Parent Drug Ratio in Renal Transplant Recipients and Healthy Volunteers

Thomas Vanhove, Hylke de Jonge, Henriëtte de Loor,

Drug Metabolism and Disposition

2018

19

Page 1